Article

Another Reason to Quit Smoking

African Americans who smoke cigarettes have a higher risk of developing rheumatoid arthritis.

A new study determined that African Americans who smoke cigarettes have a higher risk of developing rheumatoid arthritis (RA).

RA risk is more pronounced among individuals positive for the HLA-DRB1 shared epitope, a genetic risk factor for RA. Findings from this study the largest to date examining the impact of smoking on RA risk in an African American population are available in the December issue of Arthritis & Rheumatism.

RA is a chronic inflammatory disease that affects the joint lining and causes pain, swelling, and redness in the joints. The ACR estimates that 1.3 million Americans are diagnosed with RA and 75% of those are women. Prior studies suggest cigarette smoking may be associated with increased risk of developing RA. A 2009 health report compiled by the Centers for Disease Control and Prevention estimate that in the African American population, 26% of men and 17% of women 18 years of age and older smoke.

"RA epidemiology has been largely understudied in the African American population," said Ted Mikuls, MD, MSPH, from the University of Nebraska Medical Center and lead study author, according to a press release. "The aim of our study was to bridge the knowledge gap by determining whether smoking contributes to RA risk in African Americans and define the extent to which this association is affected by genetic risk."

The current study evaluated participants with RA (605) and healthy controls (255) from the Consortium for the Longitudinal Evaluations of African Americans with Early Rheumatoid Arthritis (CLEAR) I study group (RA patients with less than two years disease duration from the time of symptom onset) and the CLEAR II study group (RA patients with any disease duration). Researchers analyzed smoking status (current, former, never), cumulative smoking exposure, and genetic risk factor (HLA-DRB1 shared epitope (SE)).

Results showed that patients with RA were slightly more likely to report a status of former or current smoker and less likely to be never smokers than healthy subjects. Heavy smoking (greater than 10 pack-years) was found in 54% of RA patients and in 35% of controls who ever smoked. Researchers also found that RA patients were more likely than controls to have at least one HLA-DRB1 SE-containing allele (40% versus 23%).

Results showed that patients with RA were slightly more likely to report a status of former or current smoker and less likely to be never smokers than healthy subjects. Heavy smoking (greater than 10 pack-years) was found in 54% of RA patients and in 35% of controls who ever smoked. Researchers also found that RA patients were more likely than controls to have at least one HLA-DRB1 SE-containing allele (40% versus 23%).

"We found a two-fold increase in RA risk among African Americans who were heavy smokers, and this risk increased to more than four-fold in the presence of SE alleles," commented Dr. Mikuls. "Our results suggest that roughly one in six new cases of RA occurring in African Americans could be prevented through smoking cessation or by limiting cumulative smoking exposure to less than 10 pack-years."

Sources: Wiley - Blackwell, AlphaGalileo Foundation

--

Will you discuss the risk with your patients? Leave a comment.

Related Videos
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
© 2024 MJH Life Sciences

All rights reserved.